Doctor profile · Federal record
Dr. Michael Vincent Tablang, M.D.
Infectious Disease Physician (CMS: Infectious Disease) · Crestview, FL
- NPI 1679763387
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
351 N Ferdon Blvd
Crestview, FL 325362727
(508) 623-9798
fax (850) 862-0605 - Mailing address
-
917 Mar Walt Dr
Fort Walton Beach, FL 325476651
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- February 14, 2024
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- Florida #ME138845
- Medicaid
- FL #116653900
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1679763387. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
716,905
Distinct HCPCS
10
Medicare allowed
$2,538,916
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0878 |
Injection, daptomycin, 1 mg | 566,961 | 49 | $0 | |
J0121 |
Injection, omadacycline, 1 mg | 103,601 | 123 | $4 | |
J2406 |
Injection, oritavancin (kimyrsa), 10 mg | 23,880 | 125 | $41 | |
J0875 |
Injection, dalbavancin, 5 mg | 3,600 | 11 | $15 | |
J0692 |
Injection, cefepime hydrochloride, 500 mg | 2,523 | 25 | $1 | |
J0696 |
Injection, ceftriaxone sodium, per 250 mg | 2,503 | 65 | $1 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 2,092 | 223 | $61 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,843 | 360 | $124 | |
J1335 |
Injection, ertapenem sodium, 500 mg | 1,808 | 82 | $13 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 1,714 | 612 | $117 |
In context: peer comparison
Among 1 peers in Crestview Infectious Disease Physician, average services per provider: 23,896. This provider delivers 30× the peer median.Open Payments
Industry payments received
All-time total
$413
Transactions
23
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ViiV Healthcare Company | 9 | $154.35 | |
| Abbvie INC. | 3 | $64.44 | |
| Merck Sharp & Dohme LLC | 3 | $56.71 | |
| Insmed, INC. | 3 | $54.52 | |
| Mimedx Group, INC. | 3 | $51.42 | |
| Paratek Pharmaceuticals, INC. | 1 | $18.71 | |
| Urgo Medical North America, LLC | 1 | $13.27 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
562
Patients
213
Total drug cost
$403,012
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Daptomycin | Generic | 79 | 16 | $161,978 |
| Cefdinir | Generic | 66 | 45 | $5,067 |
| Doxycycline Hyclate | Generic | 64 | 44 | $2,908 |
| Fluconazole | Generic | 49 | 29 | $754 |
| Octagam (Immun Globg(Igg)/Malt/Iga Ov50) | Brand | 39 | 0 | $97,280 |
| Sodium Chloride (0.9 % Sodium Chloride) | Brand | 32 | 12 | $493 |
| Ceftriaxone (Ceftriaxone Sodium) | Brand | 31 | 0 | $3,996 |
| Ertapenem (Ertapenem Sodium) | Brand | 30 | 11 | $20,666 |
| Meropenem | Generic | 29 | 0 | $7,506 |
| Cefadroxil | Generic | 27 | 16 | $1,074 |
Hospital affiliations
Frequently asked questions
What is Dr. Michael Vincent Tablang's medical specialty?
Dr. Michael Vincent Tablang practices Infectious Disease Physician in Crestview, FL.
Where does Dr. Michael Vincent Tablang practice?
Dr. Michael Vincent Tablang practices at 351 N Ferdon Blvd, Crestview, FL 325362727. Office phone: 5086239798.
What is Dr. Michael Vincent Tablang's NPI?
Dr. Michael Vincent Tablang's National Provider Identifier (NPI) is 1679763387, issued by NPPES.
Does Dr. Michael Vincent Tablang accept Medicare assignment?
Yes. Dr. Michael Vincent Tablang accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Vincent Tablang commonly perform?
Top Medicare-reported procedures in 2023: Injection, daptomycin, 1 mg (HCPCS J0878); Injection, omadacycline, 1 mg (HCPCS J0121); Injection, oritavancin (kimyrsa), 10 mg (HCPCS J2406). Source: CMS Medicare Physician & Other Practitioners file.